根据IPSS-R,IPSS-M以及国际共识分类的MDS遗传和转录异常的预后影响
Wan-Hsuan Lee1,2,3,4, Hsin-An Hou5,6,7,8, Chien-Chin Lin1,9
1Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan, ROC.
Blood cancer journal
|March 13, 2026
概括
没有基因组异常的骨髓发育综合征 (MDS) 患者具有明显的生物学特征和有利的预后. 将临床因素与基因组数据相结合,改善了个性化MDS管理的风险分层.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
背景情况:
- 骨髓发育综合征 (MDS) 是一种克隆性造血干细胞疾病.
- 细胞遗传异常和基因突变是MDS的关键预后因素.
- 缺乏这些基因组病变的MDS患者的临床和生物学意义尚不清楚.
研究的目的:
- 为了调查MDS患者的特征和结果,没有可检测的基因组异常.
- 探索基因组负MDS的独特生物特征.
- 为MDS开发一个改进的风险分层模型.
主要方法:
- 对758名初级MDS患者的回顾性分析.
- 基于基因突变和细胞遗传异常的分层.
- 批量RNA测序用于转录概况.
- 开发一种基于Cox的多变量名图,包括临床和基因组因素.
主要成果:
- 大约20%的患者缺乏细胞遗传和基因异常.
- 基因组阴性MDS患者年轻,主要是女性,风险得分较低,生存率更高.
- 转录分析揭示了基因组阴性MDS中的独特的免疫代谢程序与基因组改变的MDS中的炎症/增殖特征.
- 开发的纳米图集了年龄,费里丁,LDH,纤维化和IPSS-M在生存预测方面超过了单独的IPSS-M.
结论:
- 缺乏基因组异常的MDS患者代表了一个生物学上独特的低风险亚组.
- 当前的风险分层系统可能低估了这些患者的良好预后.
- 结合临床,基因组和预测建模的综合方法对于准确的MDS风险评估和个性化的治疗策略至关重要.
相关概念视频
iPS Cell Differentiation
3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K


